About Pharmamark
Pharmamark is a company based in Sydney (Australia) founded in 1994 by Andre Niemann and Guy Drummond. Pharmamark has raised $3.71 million across 1 funding round from investors including BioScience Managers. Pharmamark offers products and services including IntEncap™. Pharmamark operates in a competitive market with competitors including Captek, Holista CollTech, Verdant Nature, 3i Solutions and FLUIDINOVA, among others.
- Headquarter Sydney, Australia
- Founders Andre Niemann, Guy Drummond
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Pharmamark Nutrition Pty Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.71 M (USD)
in 1 rounds
-
Latest Funding Round
$3.71 M (USD), Series A
Aug 08, 2019
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pharmamark
Pharmamark offers a comprehensive portfolio of products and services, including IntEncap™.
Encapsulates oils and fats for stable infant formula and food products.
Funding Insights of Pharmamark
Pharmamark has successfully raised a total of $3.71M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.71 million completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pharmamark
Pharmamark has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include BioScience Managers.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
BioScience Managers is engaged in healthcare investment and innovation.
|
Locked | Locked | Locked |
Investor details for Pharmamark
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharmamark
Investment portfolio details for Pharmamark
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pharmamark
Detailed financials for Pharmamark
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmamark Comparisons
Peer comparison for Pharmamark
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pharmamark
Pharmamark operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Captek, Holista CollTech, Verdant Nature, 3i Solutions and FLUIDINOVA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Custom dietary supplements are manufactured under contract by Captek.
|
|
| Locked | Locked | Locked |
Medical-grade collagen, supplements, and food ingredients are produced.
|
|
| Locked | Locked | Locked |
Developer of nutraceutical delivery system for healthy aging and metabolic health
|
|
| Locked | Locked | Locked |
Provider of contract manufacturing services
|
|
| Locked | Locked | Locked |
Synthetic nano-hydroxyapatite materials are manufactured and supplied.
|
Detailed competitors of Pharmamark
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmamark
Complete news archive for Pharmamark
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmamark
Pharmamark was founded in 1994 and raised its 1st funding round 25 years after it was founded.
Pharmamark is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Guy Drummond is the current CEO of Pharmamark. They have also founded this company.
Pharmamark is a funded company, having raised a total of $3.71M across 1 funding round to date.
Pharmamark was established in 1994 in Sydney, Australia, within the nutraceuticals sector. Microencapsulation technology is supplied by the company to safeguard sensitive bio-actives from environmental factors and improve their bioavailability. The primary offering, IntEncap, serves as a platform with 70 oil, fat, and carbohydrate composition. Additional products, including ReVite, are delivered as raw materials and ingredients to various brands. Operations focus on technology provision for bio-active compound applications.
Pharmamark's top competitors include Holista CollTech, Captek and 3i Solutions.
Pharmamark offers IntEncap™.
Pharmamark has 1 investor. Key investors include BioScience Managers.